Rapid Detection of SARS-CoV-2 Antigen from Serum in a Hospitalized Population
McAulay, K.; Kaleta, E. J.; Grys, T. E.
Show abstract
SARS-CoV-2 viremia has been demonstrated in some patients using molecular assays. Here we demonstrate detection of SARS-CoV-2 antigen in a cohort of hospitalized patients using a rapid diagnostic test from Anhui Deepblue Medical Technology Co., Ltd. We detected antigen in serum from 11 of 13 patients at time points ranging from three to eighteen days from symptom onset and observed that the disappearance of an antigen signal was associated with seroconversion. These results demonstrate proof of principle use of a rapid antigen test with serum samples in a format compatible with point of care testing.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A multicenter study to assess the performance of the point-of-care RT-PCR Cobas SARS-CoV-2 & Influenza A/B nucleic acid test for use on the Cobas Liat system in comparison with centralized assays across healthcare facilities in the United States 96%
- Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-throughput Drive-through Community Testing Site in Massachusetts 96%
- Estimating the false positive rate of highly automated SARS-CoV-2 nucleic acid amplification testing 96%
Similar papers in this journal
- Evaluation of SARS-CoV-2 Antibody Point of Care Devices in the Laboratory and Clinical Setting 95%
- Performance of the TaqMan™ COVID-19 Pooling Kit for detection of SARS-CoV-2 in Asymptomatic and Symptomatic populations at an Institution of Higher Education 95%
- Diagnostic accuracy of two commercial SARS-CoV-2 Antigen-detecting rapid tests at the point of care in community-based testing centers 95%
Similar papers in this journal
- Antigen-based testing but not real-time PCR correlates with SARS-CoV-2 virus culture 96%
- Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020 96%
- The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs 95%
Similar papers in this journal
- Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco 96%
- SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali 93%
- Screening for SARS-CoV-2 in close contacts of individuals with confirmed infection: performance and operational considerations 93%
Similar papers in this journal
- Clinical evaluation of BD Veritor™ SARS-CoV-2 and Flu A+B Assay for point-of-care (POC) System 96%
- Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test in symptomatic populations and asymptomatic community testing 96%
- Performance of the Cue COVID-19 Molecular Test for Point of Care: Insights from a multi-site clinic service model 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.